Plasma Exeresis technology was conceived and developed by GMV, a company with over 10 years of experience in plasma technology, owned of Plexr brand, the first plasma device in the world used in aesthetic medicine, internationally patented. Applications of Plexr involve different medical disciplines: dermatology, aesthetic medicine, oculoplasty, dentistry, gynecology. The methodology and application protocols are constantly developed in collaboration with Key Opinion Leaders and prestigious universities in Italy and around the world. The results are published in scientific research and peer-reviewed journals.
Through its three handpieces, whose outputs are optimized so that an ad-hoc signal can be delivered depending on the specific treatment, Plexr ionizes the air present between its terminal and the epidermis, generating a radius of micro-plasma.
Plexr is an extremely versatile device that is used for different dermatological treatments, both aesthetic and curative.
Simple & Versatile
Plexr is suitable for many medical areas and can work both on the mucosa and on the epidermis. Technology and design make it very easy to use.
Safe & Gentle
The level of pain perceived by the patient is extremely low and does not require any anesthesia, or a slight local anesthetic in some cases. Recovery times are also very fast. International scientific studies prove its efficacy and safety.
Low costs & Certified quality
The costs for a treatment are not high and definitely lower than in traditional surgery. Plexr is a registered trademark and a certified medical device, in possession of an international patent, produced entirely in Italy by GMV and distributed in over 50 countries worldwide.
Battery
The high-capacity lithium-ion battery guarantees a duration of signal delivery up to 4 effective hours of application, with unchanged performance when the charge varies.
Software
Software can be updated directly by the customer via a USB stick supplied by GMV, which constantly develops new protocols and new features for the system.
Microprocessor
The microprocessor inserted inside the device allows to deliver a constant, precise and controlled signal. Each handpiece therefore reproduces exactly the amount of plasma needed to have the biological effects studied in accordance with the scientific literature.
Video tutorial
The device integrated video-tutorials allow the doctor to study the application of a specific protocol, and the patient to become more aware of the method and its results.
Touch screen display
The charging base has a 10.1-inch capacitive touch-screen display that allows the use of the device through a graphical interface designed to be attractive and easy to use.
Today there are millions of treatments made all over the world by the thousands of doctors who have chosen Plexr Plus in their doctor’s office. The results are immediate and long lasting and fully satisfy both the patients who undergo treatment and the doctors who perform it.
– Nejat F, Nabavi NS, Nejat MA, Aghamollaei H, Jadidi K, Safety evaluation of the plasma on ocular surface tissue: An animal study and histopathological findings. Clinical Plasma Medicine, 2019
– Rota MT. Plasma Exeresis: a novel approach to treat Gummy Smile. Prime Journal. 2019
– Sotirios TG, Nantia S. Non–Invasive Blepharoplasty with Plasma Exeresis (Plexr) Pre/Post Treatments. J Aesthet Reconstr Surg. 2018
– Rossi E, Paganelli A, Mandel VD, Pellacani G. Plasma Exeresis Treatment for Epidermoid Cysts: A Minimal Scarring Technique. Dermatol Surg. 2018
– Nalewczynska A. The use of device generating plasma for the treatment of vulvar and vagina atrophy symptoms (VVA). Plactic and Reconstructive Gynecology, 2018
– Rossi E, Paganelli A, Mandel VD, Pellacani G. Favre-Racouchot syndrome: report of a case treated by plasma exeresis. J Eur Acad Dermatol Venereol. 2018
– Rossi E, Farnetani F, Trakatelli M, Ciardo S, Pellacani G. Clinical and Confocal Microscopy Study of Plasma Exeresis for Nonsurgical Blepharoplasty of the Upper Eyelid: A Pilot Study. Dermatol Surg. 2018
– Rossi E, Mandel VD, Paganelli A, Farnetani F, Pellacani G. Plasma exeresis for active acne vulgaris: Clinical and in vivo microscopic documentation of treatment efficacy by means of reflectance confocal microscopy. Skin Res Technol. 2018
– TG Sotiris, G Nikolaos, G Irini New Treatment with Plasma Exeresis for Non-Surgical Blepharoplasty. EC Ophthalmology, 2017
– TG Sotiris, Combination of Autologous Treatments for Non–Invasive Blepharoplasty and Non–Surgical Full Face Lift. Journal of Clinical & Experimental Dermatology Research, 2017
– TG Sotiris, G Nikolaos, G Irini The Gas Ionization by Plasma Technology for Noninvasive Techniques in Oculoplastic. JOJ Ophthalmology, 2017
GMV srl
Legal and operative headquarter:
Via Roberto Paribeni 37
00173, Rome (IT)
VAT Number: IT09449991000
Pursuant to the new guidelines of the Ministry of Health of 03/28/2013, relating to health advertising concerning medical devices, the user is advised that the information contained therein is intended exclusively for professional operators.
Copyright© 2019 Gruppo GMV. All reserved rights
